HOUSE DOCKET, NO. 861        FILED ON: 1/17/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1152

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Geoff Diehl

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act establishing provisions for the return of expired pharmaceuticals.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Geoff Diehl

7th Plymouth

1/17/2017

David F. DeCoste

5th Plymouth

 

Shaunna L. O'Connell

3rd Bristol

 


HOUSE DOCKET, NO. 861        FILED ON: 1/17/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1152

By Mr. Diehl of Whitman, a petition (accompanied by bill, House, No. 1152) of Geoff Diehl, David F. DeCoste and Shaunna L. O'Connell relative to establishing provisions for the return of expired pharmaceuticals.  Public Health.

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1925 OF 2015-2016.]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act establishing provisions for the return of expired pharmaceuticals.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1.

Chapter 94C of the General Laws is hereby amended by inserting after Section 15, the following Section:-

Section 15A

Provisions for the return of outdated drugs.

(a) Persons who manufacture controlled substances shall make adequate provision for the return of outdated drugs from pharmacies, both full and partial containers, excluding biological, infused or intravenously injected drugs and drugs that are inhaled during surgery, within six (6) months after the labeled expiration date, for prompt full credit or refund.

(b) Any person who is engaged in the wholesale drug business licensed under section 36A of chapter 112 shall implement and administer the return policies established by the manufacturer.

(c) Manufacturers will provide the Department of Public Health with information regarding said return policy, in a format to be determined by the Commissioner.

(d) Failure to comply with the provisions of this section will permit the Commissioner to list the manufacturer's products as ineligible for use in product selection for any state funded program.

SECTION 2.

The Commissioner shall promulgate regulations to enforce this act.